There is growing evidence that excess generation of highly reactive free radicals, largely due to hyperglycemia, causes oxidative stress which further exacerbates the development and progression of diabetes and its complications. There are multiple sources of oxidative stress in diabetes including non-enzymatic, enzymatic, and mitochondrial pathways. Vitamin E is a fat-soluble vitamin that prevents lipid peroxidation. Objective: the present study was carried out to test the effect of vitamin E on blood glucose, insulin, and lipid peroxides in blood and liver tissue of rats in relation to oxidative damage associated with diabetes induced by streptozotocin (STZ). Methods: 24 male albino rats were randomly assigned to control (group I), streptozotocin (STZ)-induced diabetic rats (group II), the third group (vitamin E group) were STZ-induced diabetic rats fed 400 mg of vitamin E/kg diet. After 4 weeks of the induction of diabetes, rats were sacrificed and the following determinations were done on the blood, serum or plasma. Blood glucose, serum insulin, lipid peroxide concentration in plasma as malonyldialdehyde (MDA) level in nmol/g protein, the amount of thiobarbituricp acid reactive materials in plasma (TBARM), serum antioxidant capacity (assayed by measuring the total peroxy radical trapping capacity (TRAP) of serum, and serum superoxide dismutase, enzyme activity (SOD). In the liver, the following parameters were determined: liver MDA, SOD and Glutathione peroxidase (GSH-Px) enzyme activaties, and Glutathione (GSH) concentration. Results: Hyperglycemia, hypoinsulinemia were regarded in group II which were ameliorated by vitamin E administration. Oxidant stress was found in diabetic rats group II manifested by increase concentration of MDA-plasma and liver, increase TBARM concentration, and TRAP-plasma and serum respectively. Also increased serum SOD, liver SOD, and GSH-Px enzyme activities in these diabetic rats. Administration of vitamin E in the diet decreased the oxidant stress parameters (MDA, TBARM, and TRAP), increased the antioxidant defense parameter (increased GSH concentration in liver), and decreased the oxidant stress as manifested by the decrease in serum SOD enzyme activity; liver SOD; and GSH-Px enzyme activities. Conclusion: Vitamin E was found to be excellent for strengthening the antioxidant defense system in STZdiabetic rats and it may therefore have a therapeutic role in combating the damaging effect of ROS in diabetes and preventing its complications.
INTRODUCTION
Elevated glucose levels are associated with increased production of reactive oxygen species (ROS) mainly through the glycation reaction which occurs in various tissues. (1) In addition, superoxide ( ) The present study was designed to investigate the role of vitamin E as an antioxidant supplemented to rat's diet in the amelioration of lipid peroxidation process, in both the blood and liver of streptozotocin (STZ)-induced diabetic rats and its role in strengthening the antioxidant system of them.
MATERIAL AND METHODS
Twenty-four male albino rats (200-250 g.) were used in the present study. All rats were fed rat chow and water. They were divided randomly into 3 groups.
Group I (n = 8) is the control group, which was injected with sterilized buffer.
Group II (n = 8) was made diabetic by single intraperitoneal injection of streptozotocin (STZ) 40 mg/kg (4) body wt.
Diabetes was verified by hyperglycemia which developed 3 days after STZ injection.
Group III was diabetic-induced rats like group II but received -tocopherol (vitamin E) with diet (400 mg/kg rat chow). (5) Rats were sacrificed by decapitation 4 weeks later. Blood was collected. Part of the blood was left to clot and centrifuged at 3000 r.p.m for 30 minutes to separate the serum.
The remaining blood was mixed with EDTA to separate plasma.
The liver was separated, rinsed in ice cold phosphate buffer saline (PBS pH 7. Serum, plasma, and liver samples were kept at -70°C till analysis. Supernatant fractions from liver homogenates were prepared by centrifugation at 10,000 g. for 10 min at 4°C. (6) Protein concentrations in liver homogenates supernatants were estimated by the method of Lowry et al. (7) Blood glucose was determined by glucose oxidase method (8) . a-Glutathione content (14) (GSH).
b-Glutathione peroxidase enzyme activity (15) (GSH-Px).
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STATISTICAL ANALYSIS
The results of the present study was statistically analyzed using Statistical Package for Social Sciences (SPSS) (17) for Windows version 9.0 software.
RESULTS
No difference in food intake or body weight was observed among the 3 groups 
DISCUSSION
There is growing evidence that excess generation of highly reactive free radicals, largely due to hyperglycemia causes oxidative stress, (1) which further exacerbates the development and progression of diabetes and its complications. Overproduction and/or insufficient removal of these free radicals results in vascular dysfunction, damage to cellular proteins, membrane lipids, and nucleic acids. (2) There are multiple sources of oxidative stress in diabetes including non-enzymatic, O production. (19, 20) 24
There is enhanced production of ( )
diabetes predominantly produced by NAD (P) H oxidase. (19) The mitochondrial respiratory chain is another source of non-enzymatic generation of reactive species. A recent study demonstrated that hyperclycemia-induced generation of
O at the mitochondrial level was the initial trigger of the vicious cycle of oxidative stress in diabetes. (22, 23) The present results (Table 2) show highly significant increase (p<0.001) of MDA as a measure of lipid peroxidation in the plasma of STZ diabetic rats as a result of oxidative stress. This finding is in accordance with multiple previous results. (24) (25) (26) (27) (28) (29) Plasma TBARM and serum TRAP levels as indirect measurement of free radical production have been also shown to be constantly elevated in diabetes as recorded in previous studies (26) (27) (28) and in the present work, (Table 2) The effect of antioxidant system of the body on the oxidation stress can be measured through certain observable biomarkers. These markers include the enzyme activities of SOD, GSH-Px, and GSH-reductase as well as GSH concentration. The enzymes studied (SOD in serum and liver, GSH-Px in liver) were found to be highly significantly elevated (p<0.001) which is in accordance with previous studies. (26, 27, 30) GSH which acts as a direct scavenger as well as a co-substrate for GSH-Px was recorded to be decreased in the present study in the liver as recorded previously. (26, 27, 30) Contrary to the present results, GSH-Px expression in experimental activity were shown to be decreased in experimental models of diabetes. (21, 28, (31) (32) (33) However, Ulusu et al., (2003) (27) found that GSH-Px was increased by STZ diabetic rats in brain, heart, and kidney. Hunkar et al., (2002) (25) recorded an increased activity of the enzyme in the aorta, heart, and liver. The same enzyme activity was found to be increased in the brain, heart, and kidney (20) , and RBCs. (16) In the present study, it is evident that antioxidant treatment with vitamin E can improve the glycemic control with preservation of pancreatic -cell function of STZ diabetic rats by increasing the level of insulin ( Table 1 ).
The antioxidant treatment probably exerts its effects in association with the presence of hyperglycemia, i.e., by protecting -cells from the toxic effects of ROS produced under hyperglycemic condition.
Kaneto et al., (1999) (1) found that the antioxidant treatment increased the -cell mass and preserved its insulin content, using immunostaining technique for pancreatic sections of STZ rats treated with antioxidants.
Recently Al-Shamsi et al., (2006) (34) found that vitamin E significantly increased plasma insulin level in normal rats but failed to increase the plasma insulin level in diabetic rats. In the present study, vitamin E indeed reduced blood glucose level and increased insulin level (Table   1 ). Thus vitamin E may play a role in glucose metabolism and thus be a useful adjuvant therapy in type I diabetes. (35) In the plasma and liver, it decreased lipid peroxides (MDA) and SOD enzyme activity, GSH-Px enzyme activity in liver, and increased GSH concentration in liver (Tables 2 & 3) . Similar results were obtained by several authors, (27, 33, (36) (37) (38) (39) (40) (41) (42) who found that vitamin E was effective in reducing several indices of oxidative stress including lipid peroxides. Also the present study showed decrease of other oxidant stress markers, i.e., plasma TBARM and serum TRAP (Table 2) . Concerning the mechanism of action of vitamin E, Garg and Bansal (2000) (44) suggest that vitamins C and E reduce lipid peroxidation by quenching free radicals. Hong et al., (5) suggest that vitamin E reduces the generation of ROS and damages the oxidative substances.
Kaneto et al., (1999) (1) The present results therefore clearly demonstrates that vitamin E supplementation augments the antioxidant defense mechanism in diabetes, and provides evidence that vitamin E may have a therapeutic role in combating free radical mediated disease 
